Drug profile · INN
clioquinol
NYSTAFORM
clioquinol (NYSTAFORM) is a copper chelating agent. Route of administration: topical. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — clioquinol
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
clioquinol (NYSTAFORM) is a copper chelating agent. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN clioquinol
Brand NYSTAFORM
Mechanism Copper chelating agent
Target Copper
Route TOPICAL
Formulation OINTMENT
Mechanism of action
Copper chelating agent
Primary target: Copper
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clioquinol?
clioquinol (NYSTAFORM) is a copper chelating agent. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for clioquinol?
NYSTAFORM is a marketed brand name for clioquinol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clioquinol?
clioquinol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.